Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.

netcare Linksfield Hospital is a trusted healthcare provider for Blalock–Thomas–Taussig shunt (BT Shunt), offering specialised congenital heart surgery supported by experienced pediatric cardiologists, cardiothoracic surgeons, and intensivists, as well as modern cardiac infrastructure. Established in 1991, the COHSASA hospital is situated in Johannesburg, South Africa and has 319 beds.
Blalock-Thomas-Taussig Shunt is a palliative procedure designed to increase pulmonary blood flow in children with certain cyanotic congenital heart conditions. The shunt connects a systemic arterial blood supply to the pulmonary circulation, allowing additional blood to reach the lungs for oxygenation. It may be performed when native pulmonary blood flow is inadequate and is often part of a staged surgical pathway before further corrective or palliative procedures. Echocardiography, cardiac catheterisation, and other investigations may be used to plan treatment.
Yashoda Hospital, Malakpet provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 1989, the NABH, NABL hospital is located in Hyderabad, India and operates 404 beds with modern pediatric cardiac infrastructure.
A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.
Ruby Hall Clinic offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 1959, the NABH, NABL hospital is located in Pune, India and has 600 beds, providing comprehensive congenital heart care for local and international patients.
A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.
Aster CMI Hospital is a trusted healthcare provider for Blalock–Thomas–Taussig shunt (BT Shunt), offering specialised congenital heart surgery supported by experienced pediatric cardiologists, cardiothoracic surgeons, and intensivists, as well as modern cardiac infrastructure. Established in 2014, the JCI, NABH, NABL hospital is situated in Bangalore, India and has 500 beds.
Blalock-Thomas-Taussig Shunt is a palliative procedure designed to increase pulmonary blood flow in children with certain cyanotic congenital heart conditions. The shunt connects a systemic arterial blood supply to the pulmonary circulation, allowing additional blood to reach the lungs for oxygenation. It may be performed when native pulmonary blood flow is inadequate and is often part of a staged surgical pathway before further corrective or palliative procedures. Echocardiography, cardiac catheterisation, and other investigations may be used to plan treatment.
Durban, South Africa
Lenmed Ethekwini Hospital and Heart Centre provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 2002, the hospital is located in Durban, South Africa and operates 353 beds with modern pediatric cardiac infrastructure.
A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.
Burjeel Medical City is a trusted healthcare provider for Blalock–Thomas–Taussig shunt (BT Shunt), offering specialised congenital heart surgery supported by experienced pediatric cardiologists, cardiothoracic surgeons, and intensivists, as well as modern cardiac infrastructure. Established in 2017, the ISO hospital is situated in Abu Dhabi, United Arab Emirates and has 350 beds.
Blalock-Thomas-Taussig Shunt is a palliative procedure designed to increase pulmonary blood flow in children with certain cyanotic congenital heart conditions. The shunt connects a systemic arterial blood supply to the pulmonary circulation, allowing additional blood to reach the lungs for oxygenation. It may be performed when native pulmonary blood flow is inadequate and is often part of a staged surgical pathway before further corrective or palliative procedures. Echocardiography, cardiac catheterisation, and other investigations may be used to plan treatment.
Choosing MGM Healthcare for Blalock–Thomas–Taussig shunt (BT Shunt) gives patients access to experienced pediatric cardiac specialists, advanced operating facilities, and specialised postoperative cardiac intensive care. Established in 2016, the NABH, NABL, JCI hospital in Chennai, India has 400 beds and provides comprehensive congenital heart services.
A Blalock-Thomas-Taussig Shunt (BT Shunt) may be considered when a congenital heart defect causes insufficient pulmonary blood flow and low oxygen levels. The procedure establishes a controlled connection between a systemic artery and a pulmonary artery via a vascular graft, thereby increasing blood flow to the lungs. Doctors evaluate the child's anatomy, oxygen saturation, pulmonary arteries, and overall clinical condition before surgery. After the procedure, close monitoring is required to assess oxygenation, circulation, and shunt patency.
Choosing Medipol Mega University Hospital for Blalock–Thomas–Taussig shunt (BT Shunt) gives patients access to experienced pediatric cardiac specialists, advanced operating facilities, and specialised postoperative cardiac intensive care. Established in 2012, the JCI hospital in Istanbul, Turkey has 810 beds and provides comprehensive congenital heart services.
A Blalock-Thomas-Taussig Shunt (BT Shunt) may be considered when a congenital heart defect causes insufficient pulmonary blood flow and low oxygen levels. The procedure establishes a controlled connection between a systemic artery and a pulmonary artery via a vascular graft, thereby increasing blood flow to the lungs. Doctors evaluate the child's anatomy, oxygen saturation, pulmonary arteries, and overall clinical condition before surgery. After the procedure, close monitoring is required to assess oxygenation, circulation, and shunt patency.
Fortis Hospital offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2011, the NABH, NABL hospital is located in Kolkata, India and has 400 beds, providing comprehensive congenital heart care for local and international patients.
A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.
At NMC Specialty Hospital Al Salam, Blalock–Thomas–Taussig shunt (BT Shunt) is performed using advanced pediatric cardiac surgery techniques and individualized treatment plans based on the child's heart defect and pulmonary blood flow. Established in 1999, this CBAHI hospital in Riyadh, Saudi Arabia has 100 beds and provides comprehensive congenital heart disease services.
A BT Shunt may be recommended for selected infants and children with congenital heart defects in which blood flow to the lungs is significantly reduced. During the procedure, a synthetic vascular graft is placed between a systemic artery and the pulmonary artery to provide an alternative route for blood to reach the lungs. The shunt is generally used as part of staged treatment rather than as a definitive repair of the underlying heart defect. Careful postoperative monitoring helps assess oxygenation and shunt function.
Aster Medcity provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 2013, the NABH, JCI hospital is located in Kochi, India and operates 670 beds with modern pediatric cardiac infrastructure.
A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.
Memorial Sisli Hospital offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2000, the JCI, NABH hospital is located in Istanbul, Turkey and has 252 beds, providing comprehensive congenital heart care for local and international patients.
A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.
Dubai, United Arab Emirates
NMC Specialty Hospital, Al Nahda offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2004, the JCI hospital is located in Dubai, United Arab Emirates and has 187 beds, providing comprehensive congenital heart care for local and international patients.
A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.
At Meliva Kardiolita Hospital, Kaunas, Blalock–Thomas–Taussig shunt (BT Shunt) is performed using advanced pediatric cardiac surgery techniques and individualized treatment plans based on the child's heart defect and pulmonary blood flow. Established in 1998, this JCI hospital in Kaunas, Lithuania has 8 beds and provides comprehensive congenital heart disease services.
A BT Shunt may be recommended for selected infants and children with congenital heart defects in which blood flow to the lungs is significantly reduced. During the procedure, a synthetic vascular graft is placed between a systemic artery and the pulmonary artery to provide an alternative route for blood to reach the lungs. The shunt is generally used as part of staged treatment rather than as a definitive repair of the underlying heart defect. Careful postoperative monitoring helps assess oxygenation and shunt function.
Jaypee Hospital offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 2014, the NABH, JCI hospital is located in Noida, India and has 1200 beds, providing comprehensive congenital heart care for local and international patients.
A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.